Biogen Inc. 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-10 5:34 pm Unchanged |
2025-01-10 | 13D | Sage Therapeutics, Inc. SAGE |
BIOGEN INC. BIIB |
6,241,473 10.200% |
0 (Unchanged) |
Filing |
| 2021-01-11 4:19 pm Purchase |
2020-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BIOGEN INC. BIIB |
6,241,473 10.700% |
6,241,473 (New Position) |
Filing |